PERSPECTA

News from every angle

← Back to headlines

Pfizer's Dividend Future Amid Patent Cliff and Cancer Bet

Analysts are examining whether Pfizer's dividend can withstand an upcoming patent cliff, with a $10.5 billion cancer investment potentially holding the key to its survival.

6 Jun, 17:52 — 6 Jun, 17:52
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual82d ago

Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.

Read full article →

Related Stories

Nvidia Reports Strong Earnings Driven by Surging AI Demand

29m ago

Canada Removes U.S. Seafood From Retaliatory Tariff List Amid Trade Tensions

45m ago

Nvidia Launches Employee-Funded PAC Amid Massive Memory Chip Expansion

58m ago

TotalEnergies Completes Exit From Sanctioned Russian LNG Project

1h ago